Polysaccharide H-1-2 Ameliorates High Glucose-Induced Podocyte Dysfunction by Suppressing Epithelial-to-Mesenchymal Transition via Restoration of SIRT1 &lt;i&gt;in Vivo&lt;/i&gt; and &lt;i&gt;in Vitro&lt;/i&gt;

AimsO‐Linked β‐N‐acetylglucosamine (O‐GlcNAc) modification, a unique post‐translational modification of proteins, is elevated in diabetic nephropathy. This review aims to summarize the current knowledge on the mechanisms by which O‐GlcNAcylation of proteins contributes to the pathogenesis and progression of diabetic nephropathy, as well as the therapeutic potential of targeting O‐GlcNAc modification for its treatment.MethodsCurrent evidence in the literature was reviewed and synthesized in a narrative review.ResultsHyperglycemia increases glucose flux into the hexosamine biosynthesis pathway, which activates glucosamino‐fructose aminotransferase expression and activity, leading to the production of O‐GlcNAcylation substrate UDP‐GlcNAc and an increase in protein O‐GlcNAcylation in kidney cells. Protein O‐GlcNAcylation regulates the function of kidney cells including mesangial cells, podocytes, and proximal tubular cells, and promotes renal interstitial fibrosis, resulting in kidney damage. Current treatments for diabetic nephropathy, such as sodium‐glucose cotransporter 2 (SGLT‐2) inhibitors and renin–angiotensin–aldosterone system (RAAS) inhibitors, delay disease progression, and suppress protein O‐GlcNAcylation.ConclusionsIncreased protein O‐GlcNAcylation mediates renal cell damage and promotes renal interstitial fibrosis, leading to diabetic nephropathy. Although the full significance of inhibition of O‐GlcNAcylation is not yet understood, it may represent a novel target for treating diabetic nephropathy.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Polysaccharide H-1-2 Ameliorates High Glucose-Induced Podocyte Dysfunction by Suppressing Epithelial-to-Mesenchymal Transition via Restoration of SIRT1 <i>in Vivo</i> and <i>in Vitro</i>

Abstract: Polysaccharide H-1-2 ameliorates high glucose-induced podocyte dysfunction by suppressing epithelial-to-mesenchymal transition via restoration of SIRT1 in vivo and in vitro

Cited by 3 publications

References 33 publications

Traditional uses, phytochemical constituents, pharmacological properties, and quality control of Pseudostellaria heterophylla (Miq.) Pax

Traditional uses, phytochemical constituents, pharmacological properties, and quality control of Pseudostellaria heterophylla (Miq.) Pax

Natural polysaccharides as promising reno-protective agents for the treatment of various kidney injury

O‐linked β‐N‐acetylglucosamine (O‐GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy

Contact Info

Product

Resources

About